Our business development team is dedicated to seeking corporate and business development partnerships in stem cell research and cellular therapies development. We are interested in discussions and inquiries regarding co-development of products that aligned with our technology and business focus. Our initial development partner, Cambium Medical Technologies LLC, was founded in 2013 by four distinguished physician/scientists as a spin-out of Emory University, Atlanta, Georgia (USA). Cambium is focused on the development of superior regenerative therapies from human platelet lysate and has developed a proprietary process for the production of standardized, allogeneic, fibrinogen-depleted platelet lysate preparations for various therapeutic applications. Cambium believes that its platelet-derived products will prove to be superior to competing platelet-based products in development. The Company’s lead commercial product is a superior cell culture supplement for the stem cell growth supplement market.